The global Peritoneal Dialysis Market was valued at USD 8.89 billion in 2024 and is projected to grow from USD 9.35 billion in 2025 to USD 13.48 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.31% during the forecast period, according to Kings Research. Peritoneal dialysis is a treatment for end-stage renal disease that uses the peritoneal membrane to remove metabolic waste, excess fluid and toxins from the bloodstream. The market encompasses equipment, consumables and services used in continuous ambulatory and automated therapies.
Market Overview
The market includes manufacturers of dialysis machines, dialysate solutions, catheters and associated supplies, along with providers of home-based care and patient training. Growth is mainly due to the increasing prevalence of end-stage renal disease and a rising preference for home-based treatment. Advances in automated peritoneal dialysis systems and the adoption of wearable and portable devices are improving outcomes and convenience.
Personalized treatment regimens and digital health tools are also enhancing clinical results. Remote monitoring systems allow real-time data exchange between patients and clinicians, enabling timely interventions and proactive care adjustments. In June 2025, Vantive announced USD 1 billion over five years to expand R&D and manufacturing of digitally enabled kidney and organ support therapies, and showcased its Sharesource platform for at-home automated peritoneal dialysis at the 62nd European Renal Association Congress in Vienna.
Key Highlights from the Report
- The market was valued at USD 8.89 billion in 2024 and is projected to grow at a 5.31% CAGR from 2025 to 2032.
- North America held a 34.07% share in 2024, valued at USD 3.03 billion.
- The continuous ambulatory peritoneal dialysis (CAPD) segment generated USD 5.52 billion in revenue in 2024 and is projected to reach USD 8.30 billion by 2032.
- The solution bags segment is expected to reach USD 3.79 billion by 2032.
- The home care settings segment is projected to generate USD 4.99 billion by 2032.
- Asia Pacific is anticipated to grow at a CAGR of 6.20%, with a projected value of USD 3.22 billion in 2032.
Market Driver: Growing Chronic Kidney Disease Burden
The rising global burden of chronic kidney disease is pushing more patients toward long-term renal replacement therapies. In 2024, the Institute for Health Metrics and Evaluation reported that chronic kidney disease accounted for 44.5 million disability-adjusted life years globally in 2021, including patients with end-stage kidney disease on dialysis or with transplants. As disease progresses, demand for accessible options grows. Peritoneal dialysis is gaining traction as a less invasive alternative to hemodialysis, offering flexibility, improved quality of life and compatibility with home care. Increasing prevalence of diabetes and hypertension, key risk factors for kidney disease, is expanding the dialysis-dependent population further.
Market Challenge: Skilled Workforce and Patient Training
A shortage of trained healthcare professionals and limited patient education for home dialysis constrain expansion. Many patients, particularly in low- and middle-income regions, struggle to start and maintain therapy because of insufficient clinical support and inadequate training in aseptic technique, which raises the risk of complications such as peritonitis. Companies are investing in structured training programs and digital platforms with guided tutorials, multilingual resources and virtual nurse support to close the skills gap, expand access and improve safety.
Market Trend: Remote Monitoring and Digital Solutions
Remote patient monitoring and digital health tools support real-time data collection, better treatment adherence and early intervention. Continuous assessment outside clinical settings enhances personalization and can reduce hospitalizations. As health systems prioritize cost-effective home-based care, connected technologies are expected to improve operational efficiency and clinical outcomes, reinforcing peritoneal dialysis as a scalable, patient-centered therapy.
Segmentation Analysis
By modality: CAPD earned USD 5.52 billion in 2024, mainly due to its lower cost, minimal equipment requirements and suitability for low-resource settings. Automated peritoneal dialysis (APD) is expanding as cycler technology and home connectivity improve.
By product: Solution bags held a 28.08% share in 2024, fueled by high consumption and routine use in every dialysis cycle. Machines, catheters and transfer sets complete the product view.
By end user: Home care settings are projected to reach USD 4.99 billion by 2032, owing to rising preference for home dialysis and supportive remote patient management technologies. Hospitals and independent dialysis centers remain important care venues.
Regional Analysis
North America accounted for 34.07% of the market in 2024, valued at USD 3.03 billion. Patient-centric care models and a shift toward home dialysis in the United States and Canada, together with an established ecosystem that prioritizes early-stage kidney disease management, support adoption. In March 2025, Strive Health expanded its partnership with Zing Health to deliver value-based kidney care to eligible members across six U.S. states, using coordinated care, predictive analytics and tailored Medicare Advantage benefits. Value-based care is encouraging a shift from in-center hemodialysis toward more flexible peritoneal solutions.
Asia Pacific is expected to register the fastest CAGR, at 6.20%. A growing elderly population in densely populated countries, along with rising diabetes and hypertension, is elevating the risk of kidney disease. In February 2025, the World Health Organization reported that the global population aged 60 and over is projected to double by 2050, and in Southeast Asia is expected to rise from 77.4 million in 2020 to 173.3 million. That demographic shift is expected to increase demand for less invasive, home-based treatment.
Regulatory Landscape
In the United States, the Food and Drug Administration is the primary regulator of peritoneal dialysis systems and related devices, ensuring safety and effectiveness. In Japan, the Ministry of Health, Labour and Welfare handles administrative aspects and approvals, while the Pharmaceuticals and Medical Devices Agency reviews medical products and conducts post-market surveillance. In India, the Central Drugs Standard Control Organization regulates medical devices, including those used in peritoneal dialysis.
Competitive Landscape
The market is characterized by accelerated innovation and collaboration among device manufacturers and clinical research organizations. Companies are developing advanced automated systems that are easier to use and support the shift to home care, while outsourcing partnerships with integrated clinical, regulatory and testing services shorten time to market. In October 2024, NAMSA and Terumo entered a strategic outsourcing partnership to accelerate regulatory approval and commercialization of Terumo’s device portfolio, including peritoneal dialysis treatments. In May 2025, Byonyks received FDA 510(k) clearance for its X1 automated peritoneal dialysis cycler, becoming the third company to obtain such clearance.
Key companies profiled include Baxter, Fresenius Medical Care, B. Braun, NIPRO, Medtronic, Terumo, DaVita, JMS, Infomed, Polymedicure, Renax Biomedical Technology, Newsol Technologies, Mitra Peritoneal Dialysis System, Vivance and CloudCath.
Recent Developments
- February 2025: Baxter Kidney Care was rebranded as Vantive, an independent vital organ therapy company, following its acquisition by Carlyle. Vantive is committed to advancing home and in-clinic dialysis, including remote patient monitoring, across more than 100 countries.
Strategic Insights and Opportunities
Kings Research outlines several priorities for manufacturers, providers and policymakers. Patient selection and early education are central: many patients who could use peritoneal dialysis are not offered it because of limited awareness or clinic capacity, and programs that present modality options before kidney failure advances can increase uptake. Care pathways that support a smooth transition from chronic kidney disease management to home therapy are therefore valuable to both patients and payers.
Training and support systems are a second priority. Peritonitis is a key clinical risk, and strong aseptic technique is critical. Digital training, virtual nurse visits and remote monitoring can help patients build confidence, catch problems early and remain on therapy longer. Manufacturers that integrate these services into their product offering create a more complete value proposition than hardware or solutions alone.
Technology is a third area. Automated cyclers with connectivity features allow clinicians to review therapy data and adjust prescriptions without a clinic visit, while advances in catheter design, transfer sets and sensor technology aim to lower infection rates. Regulatory clearances for new cyclers are expanding competition and choice. Finally, reimbursement and policy influence adoption significantly. Payment models that reward home therapy and outcomes, together with local manufacturing of solution bags in emerging markets, can reduce cost and improve supply reliability. Companies that align product development, training and reimbursement strategy are expected to be best placed in this growing market.
Outlook
Kings Research expects the market to be shaped by the convergence of home therapy, automation and data. Vendors that simplify setup, embed remote monitoring and support patient training are likely to improve adherence and lower complication rates, which strengthens the case for payers and health systems to favor peritoneal options. In emerging economies, affordable CAPD solutions and workforce development will remain central to expanding access, while North America continues to lead in technology adoption and reimbursement innovation.
About Kings Research
Kings Research is a market research and consulting firm that publishes syndicated reports and custom studies across healthcare, chemicals, materials, energy, technology and consumer sectors. Its reports combine quantitative market sizing with analysis of drivers, challenges, trends, regulation and competitive strategy to support business decisions.
Media Contact: Kings Research | 5348 Vegas Dr. Suite 305, Las Vegas, NV 89108 | [email protected]
